Human β-Cell proliferation and intracellular signaling: Part 3

Diabetes

Volumn 64, Issue 6, 2015, Pages 1872-1885

  Stewart, Andrew F ^a   Hussain, Mehboob A ^b   García Ocaña, Adolfo ^a   Vasavada, Rupangi C ^a   Bhushan, Anil ^c   Bernal Mizrachi, Ernesto ^d,e   Kulkarni, Rohit N ^f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CANNABINOID RECEPTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INTEGRIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; PARATHYROID HORMONE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROGESTERONE; PROTEIN KINASE C ZETA; SOMATOMEDIN; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; INSULIN;

ARTICLE; CADAVER; CELL COMMUNICATION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSDIFFERENTIATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; KNOWLEDGE BASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RODENT; STEM CELL; ANIMAL; CYTOLOGY; DIABETES MELLITUS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; SIGNAL TRANSDUCTION;

EID: 84964697600     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1843     Document Type: Article

References (118)

1. Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF. Human b-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 2012;61:2205-2213.
2. Bernal-Mizrachi E, Kulkarni RN, Scott DK, Mauvais-Jarvis F, Stewart AF, Garcia-Ocaña A. Human b-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 2014;63:819-831.
3. Kiu H, Nicholson SE. Biology and significance of the JAK/STAT signalling pathways. Growth Factors 2012;30:88-106.
4. Stark GR, Darnell JE Jr. The JAK-STAT pathway at twenty. Immunity 2012; 36:503-514.
5. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012;36:542-550.
6. Zhuang S. Regulation of STAT signaling by acetylation. Cell Signal 2013; 25:1924-1931.
7. Brooks AJ, Dai W, O'Mara M, et al. Mechanism of action of protein kinase JAK2 by the growth hormone receptor. Science 2014;344:710.
8. Linossi EM, Babon JJ, Hilton DJ, Nicholson SE. Suppression of cytokine signaling: The SOCS perspective. Cytokine Growth Factor Rev 2013;24:241-248.
9. Shuai K, Liu B. Regulation of gene- Activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 2005;5:593-605.
10. Xu J, Zhang Y, Berry PA, et al. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol 2011;25:597-610.
11. Nyga R, Pecquet C, Harir N, et al. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochem J 2005;390:359-366.
12. Amaral MEC, Cunha DA, Anhê GF, et al. Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J Endocrinol 2004;183:469-476.
13. Doche ME, Bochukova EG, Su HW, et al. Human SH2B1 mutations are associated with maladaptive behaviors and obesity. J Clin Invest 2012;122: 4732-4736.
14. Yamauchi T, Kaburagi Y, Ueki K, et al. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 1998;273:15719-15726.
15. Binart N, Bachelot A, Bouilly J. Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab 2010;21:362-368.
16. Ma F, Wei Z, Shi C, et al. Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet b-cells. Mol Endocrinol 2011;25:2119-2133.
17. Vasavada RC, Garcia-Ocaña A, Zawalich WS, et al. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 2000;275: 15399-15406.
18. Freemark M, Avril I, Fleenor D, et al. Targeted deletion of the PLR: Effects on islet development, insulin production and glucose tolerance. Endocrinology 2002;143:1378-1385.
19. Huang C, Snider F, Cross JC. Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 2009;150:1618-1626.
20. Stout LE, Svensson AM, Sorenson RL. Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 1997;138:1592-1603.
21. Rieck S, Kaestner KH. Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 2010;21:151-158.
22. Lee J-Y, Gavrilova O, Davani B, et al. The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging. Biochim Biophys Acta 2007;1773:1455-1461.
23. Jackerott M, Møldrup A, Thams P, et al. STAT5 activity in pancreatic betacells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes 2006;55:2705-2712.
24. Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007;318:806-809.
25. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 2010;16:804-808.
26. Schraenen A, Lemaire K, de Faudeur G, et al. Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia 2010;53:2589-2599.
27. Lee J-Y, Hennighausen L. The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function. Biochem Biophys Res Commun 2005;334:764-768.
28. Mziaut H, Kersting S, Knoch K-P, et al. ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs. Proc Natl Acad Sci USA 2008;105:674-679.
29. Morris DL, Cho KW, Zhou Y, Rui L. SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes 2009;58:2039-2047.
30. Choi D, Schroer SA, Lu SY, et al. Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. J Exp Med 2010;207:2831-2842.
31. Jiao Y, Rieck S, Le Lay J, Kaestner KH. CISH has no non-redundant functions in glucose homeostasis or beta cell proliferation during pregnancy in mice. Diabetologia 2013;56:2435-2445.
32. Puff R, Dames P, Weise M, Göke B, Parhofer K, Lechner A. No nonredundant function of suppressor of cytokine signaling 2 in insulin producing b-cells. Islets 2010;2:252-257.
33. Lindberg K, Rønn SG, Tornehave D, et al. Regulation of pancreatic betacell mass and proliferation by SOCS-3. J Mol Endocrinol 2005;35:231-243.
34. Banks AS, Li J, McKeag L, et al. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J Clin Invest 2005;115:2462-2471.
35. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010;53:2167-2176.
36. Parnaud G, Bosco D, Berney T, et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008;51:91-100.
37. Thakker R. Multiple endocrine neoplasia type 1. In Endocrinology. 6th ed. DeGroot L, Jameson L, Eds. Philadelphia, Saunders Elsevier, 2010, p. 2719-2741.
38. Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F, Seufert J. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Diabetes 2005;54:3410-3417.
39. Santangelo C, Scipioni A, Marselli L, Marchetti P, Dotta F. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. Eur J Endocrinol 2005;152:485-489.
40. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen- Activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 2001; 22:153-183.
41. Malumbres M, Barbacid M. RAS oncogenes: The first 30 years. Nat Rev Cancer 2003;3:459-465.
42. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF- Alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 2002;51:966-976.
43. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ. Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic betacells. Diabetes 2003;52:974-983.
44. Kim TK, Lee JS, Jung HS, et al. Triiodothyronine induces proliferation of pancreatic b-cells through the MAPK/ERK pathway. Exp Clin Endocrinol Diabetes 2014;122:240-245.
45. Friedrichsen BN, Neubauer N, Lee YC, et al. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 2006;188:481-492.
46. Schuppin GT, Pons S, Hügl S, et al. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth. Diabetes 1998;47:1074-1085.
47. Beith JL, Alejandro EU, Johnson JD. Insulin stimulates primary beta-cell proliferation via Raf-1 kinase. Endocrinology 2008;149:2251-2260.
48. Chen H, Gu X, Liu Y, et al. PDGF signalling controls age-dependent proliferation in pancreatic b-cells. Nature 2011;478:349-355.
49. Vasavada RC, Wang L, Fujinaka Y, et al. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: An essential role in growth factor mediated beta-cell mitogenesis. Diabetes 2007;56:2732-2743.
50. Bernal-Mizrachi E, Wen W, Srinivasan S, Klenk A, Cohen D, Permutt MA. Activation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells. Am J Physiol Endocrinol Metab 2001;281: E1286-E1299.
51. Gupta RK, Gao N, Gorski RK, et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev 2007;21:756-769.
52. Font de Mora J, Esteban LM, Burks DJ, et al. Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 2003;22:3039-3049.
53. Nakamura K, Ichise H, Nakao K, et al. Partial functional overlap of the three ras genes in mouse embryonic development. Oncogene 2008;27:2961-2968.
54. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008;9:517-531.
55. Chamberlain CE, Scheel DW, McGlynn K, et al. Menin determines K-RAS proliferative outputs in endocrine cells. J Clin Invest 2014;124:4093-4101.
56. Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011;331: 1199-1203.
57. House MG, Herman JG, Guo MZ, et al. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 2003;238:423- 431; discussion 431-432.
58. Wakae-Takada N, Xuan S, Watanabe K, Meda P, Leibel RL. Molecular basis for the regulation of islet beta cell mass in mice: The role of E-cadherin. Diabetologia 2013;56:856-866.
59. Diaferia GR, Jimenez-Caliani AJ, Ranjitkar P, et al. b1 integrin is a crucial regulator of pancreatic b-cell expansion. Development 2013;140:3360-3372.
60. Riopel M, Krishnamurthy M, Li J, Liu S, Leask A, Wang R. Conditional b1- integrin-deficient mice display impaired pancreatic b cell function. J Pathol 2011; 224:45-55.
61. Saleem S, Li J, Yee SP, Fellows GF, Goodyer CG, Wang R. beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival. J Pathol 2009;219:182-192.
62. Parnaud G, Gonelle-Gispert C, Morel P, et al. Cadherin engagement protects human b-cells from apoptosis. Endocrinology 2011;152:4601-4609.
63. Parnaud G, Lavallard V, Bedat B, et al. Cadherin engagement improves insulin secretion of single human b-cells. Diabetes 2015;64:887-896.
64. Amisten S, Salehi A, Rorsman P, Jones PM, Persaud SJ. An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 2013;139:359-391.
65. Ahrén B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 2009;8:369-385.
66. Pierce KL, Premont RT, Lefkowitz RJ. Seven- Transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-650.
67. Luttrell LM, Lefkowitz RJ. The role of beta- Arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002;115: 455-465.
68. Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005;85:1303-1342.
69. Shibasaki T, Takahashi H, Miki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA 2007;104:19333-19338.
70. Kelly P, Bailey CL, Fueger PT, Newgard CB, Casey PJ, Kimple ME. Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation. J Biol Chem 2010;285: 15777-15785.
71. Song WJ, Seshadri M, Ashraf U, et al. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab 2011;13:308-319.
72. Kaihara KA, Dickson LM, Jacobson DA, et al. b-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion. Diabetes 2013;62:1527-1536.
73. Lester LB, Langeberg LK, Scott JD. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA 1997;94: 14942-14947.
74. Hinke SA, Navedo MF, Ulman A, et al. Anchored phosphatases modulate glucose homeostasis. EMBO J 2012;31:3991-4004.
75. Talbot J, Joly E, Prentki M, Buteau J. b-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic b INS832/13 cells. Mol Cell Endocrinol 2012;364:65-70.
76. Quoyer J, Longuet C, Broca C, et al. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta- Arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J Biol Chem 2010;285:1989-2002.
77. Ravier MA, Leduc M, Richard J, et al. b-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice. Diabetologia 2014;57:532- 541.
78. Zhang M, Zhu Y, Mu K, et al. Loss of b- Arrestin2 mediates pancreatic-islet dysfunction in mice. Biochem Biophys Res Commun 2013;435:345-349.
79. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-837.
80. Lavine JA, Attie AD. Gastrointestinal hormones and the regulation of b-cell mass. Ann N Y Acad Sci 2010;1212:41-58.
81. Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003;17: 1575-1580.
82. Cornu M, Modi H, Kawamori D, Kulkarni RN, Joffraud M, Thorens B. Glucagon-like peptide-1 increases b-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. J Biol Chem 2010;285:10538-10545.
83. Xie J, El Sayed NM, Qi C, Zhao X, Moore CE, Herbert TP. Exendin-4 stimulates islet cell replication via the IGF1 receptor activation of mTORC1/S6K1. J Mol Endocrinol 2014;53:105-115.
84. Inada A, Hamamoto Y, Tsuura Y, et al. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol 2004;24:2831-2841.
85. Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic b-cell mass. Diabetes 2006; 55:1190-1196.
86. Bastien-Dionne PO, Valenti L, Kon N, Gu W, Buteau J. Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic b-cell mass expansion. Diabetes 2011;60:3217-3222.
87. Tschen SI, Georgia S, Dhawan S, Bhushan A. Skp2 is required for incretin hormone-mediated b-cell proliferation. Mol Endocrinol 2011;25:2134-2143.
88. Renner S, Fehlings C, Herbach N, et al. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucosedependent insulinotropic polypeptide function. Diabetes 2010;59:1228-1238.
89. Rutti S, Sauter NS, Bouzakri K, Prazak R, Halban PA, Donath MY. In vitro proliferation of adult human beta-cells. PLoS One 2012;7:e35801.
90. Tian L, Gao J, Weng G, et al. Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts. Transpl Int 2011;24:856-864.
91. Odori S, Hosoda K, Tomita T, et al. GPR119 expression in normal human tissues and islet cell tumors: Evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function. Metabolism 2013;62:70-78.
92. Zhang M, Feng Y, Wang J, et al. High- Throughput screening for GPR119 modulators identifies a novel compound with anti-diabetic efficacy in db/db mice. PLoS One 2013;8:e63861.
93. Ahlkvist L, Brown K, Ahrén B. Upregulated insulin secretion in insulinresistant mice: Evidence of increased islet GLP1 receptor levels and GPR119- Activated GLP1 secretion. Endocr Connect 2013;2:69-78.
94. Gao J, Tian L, Weng G, et al. Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int 2011;24:1124-1134.
95. Tang C, Ahmed K, Gille A, et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat Med 2015;21: 173-177.
96. Mozar A, Guthalu NK, Pollack I, Fenutria R, Vasavada RC. The role of PTHrP in pancreatic beta cells and implications for diabetes pathophysiology and treatment. Clin Rev Bone Miner Metab 2014;12:165-177.
97. Williams K, Abanquah D, Joshi-Gokhale S, et al. Systemic and acute administration of parathyroid hormone-related peptide(1-36) stimulates endogenous beta cell proliferation while preserving function in adult mice. Diabetologia 2011;54:2867-2877.
98. Guthalu NK, Joshi-Gokhale S, Harb G, et al. Parathyroid hormone-related protein enhances human b-cell proliferation and function with simultaneous induction of cyclin-dependent kinase 2 and cyclin E expression. Diabetes 2010; 59:3131-3138.
99. Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handbook Exp Pharmacol 2011;203:75-104.
100. Bermúdez-Silva FJ, Suárez J, Baixeras E, et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008;51:476-487.
101. Kim W, Doyle ME, Liu Z, et al. Cannabinoids inhibit insulin receptor signaling in pancreatic b-cells. Diabetes 2011;60:1198-1209.
102. Li C, Vilches-Flores A, Zhao M, Amiel SA, Jones PM, Persaud SJ. Expression and function of monoacylglycerol lipase in mouse b-cells and human islets of Langerhans. Cell Physiol Biochem 2012;30:347-358.
103. Jourdan T, Godlewski G, Cinar R, et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 2013;19:1132-1140.
104. Kim W, Lao Q, Shin YK, et al. Cannabinoids induce pancreatic b-cell death by directly inhibiting insulin receptor activation. Sci Signal 2012;5:ra23.
105. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009;136:3699-3714.
106. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009;19:385-394.
107. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-b family signalling. Nature 2003;425:577-584.
108. Massagué J. TGFb signalling in context. Nat Rev Mol Cell Biol 2012;13: 616-630.
109. Smart NG, Apelqvist AA, Gu X, et al. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol 2006;4:e39.
110. El-Gohary Y, Tulachan S, Wiersch J, et al. A smad signaling network regulates islet cell proliferation. Diabetes 2014;63:224-236.
111. Xiao X, Gaffar I, Guo P, et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci USA 2014;111:E1211- E1220.
112. Lin HM, Lee JH, Yadav H, et al. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 2009;284:12246-12257.
113. Blum B, Roose AN, Barrandon O, et al. Reversal of b cell de-differentiation by a small molecule inhibitor of the TGFb pathway. eLife 2014;3:e02809.
114. Brown ML, Schneyer AL. Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis. Trends Endocrinol Metab 2010;21:441-448.
115. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets. Islets 2011;3:367-375.
116. Mukherjee A, Sidis Y, Mahan A, et al. FSTL3 deletion reveals roles for TGF-b family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci USA 2007;104:1348-1353.
117. Wu H, Mezghenna K, Marmol P, et al. Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands. Diabetologia 2014;57:148-156.
118. Bruun C, Christensen GL, Jacobsen MLB, et al. Inhibition of beta cell growth and function by bone morphogenetic proteins. Diabetologia 2014;57: 2546-2554.